TNYA Tenaya Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TNYA

Price (delayed)

$4.68

Market cap

$367.46M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.68

Enterprise value

$334.2M

Highlights
The EPS has increased by 39% year-on-year and by 9% since the previous quarter
The net income is up by 2.8% since the previous quarter
The debt has declined by 18% year-on-year but it has grown by 3.2% since the previous quarter
TNYA's equity is down by 43% YoY and by 15% from the previous quarter
The quick ratio is down by 40% YoY and by 27% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of TNYA
Market
Shares outstanding
78.52M
Market cap
$367.46M
Enterprise value
$334.2M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.29
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$124.08M
EBITDA
-$112.27M
Free cash flow
-$103.31M
Per share
EPS
-$1.68
Free cash flow per share
-$1.4
Book value per share
$2.05
Revenue per share
$0
TBVPS
$2.31
Balance sheet
Total assets
$170.52M
Total liabilities
$31.09M
Debt
$12.42M
Equity
$139.42M
Working capital
$88.85M
Liquidity
Debt to equity
0.09
Current ratio
4.91
Quick ratio
4.6
Net debt/EBITDA
0.3
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-59.8%
Return on equity
-69.9%
Return on invested capital
-94.8%
Return on capital employed
-84%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNYA stock price

How has the Tenaya Therapeutics stock price performed over time
Intraday
1.3%
1 week
8.58%
1 month
-2.3%
1 year
-20.81%
YTD
44.44%
QTD
-10.52%

Financial performance

How have Tenaya Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$131.19M
Net income
-$124.08M
Gross margin
N/A
Net margin
N/A
The operating income has declined by 4.4% year-on-year but it has grown by 2.3% since the previous quarter
The net income is up by 2.8% since the previous quarter

Growth

What is Tenaya Therapeutics's growth rate over time

Valuation

What is Tenaya Therapeutics stock price valuation
P/E
N/A
P/B
2.29
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 39% year-on-year and by 9% since the previous quarter
TNYA's P/B is 64% above its last 4 quarters average of 1.4
TNYA's equity is down by 43% YoY and by 15% from the previous quarter

Efficiency

How efficient is Tenaya Therapeutics business performance
TNYA's ROIC has shrunk by 61% YoY and by 8% QoQ
Tenaya Therapeutics's return on equity has decreased by 29% YoY and by 11% QoQ
The ROA has contracted by 26% YoY and by 10% from the previous quarter

Dividends

What is TNYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNYA.

Financial health

How did Tenaya Therapeutics financials performed over time
The quick ratio is down by 40% YoY and by 27% QoQ
Tenaya Therapeutics's total assets has decreased by 39% YoY and by 12% from the previous quarter
The debt is 91% smaller than the equity
TNYA's debt to equity has surged by 50% year-on-year and by 29% since the previous quarter
TNYA's equity is down by 43% YoY and by 15% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.